Slovenia's Krka sees first-half group sales down 3 pct (updated)

Krka dd Novo Mesto

18/06/2015 15:48

(Adds details, shares) 
    LJUBLJANA, June 18 (Reuters) - Slovenian generic drugs 
producer Krka  KRKG.LJ  expects group sales in the first half of 
the year to fall 3 percent to some 580 million euros ($661 
million), due to lower sales in eastern and southeast Europe, 
the company said in a statement on Thursday. 
    Krka said its biggest sales growth is expected in western 
Europe, while sales in Slovenia will remain unchanged from last 
year. The company will release results for the first half of 
2015 on July 30. 
    Krka also said shareholders had approved a dividend of 2.2 
euros per share, up 4.8 percent from last year.  
    Shares of Krka, which is Slovenia's largest listed company, 
closed 0.5 percent higher at 67.3 euros, before the statement 
was released, while the blue-chip SBI index  .SBITOP  lost 0.8 
percent.  
($1 = 0.8769 euros) 
 
 (Reporting by Marja Novak; Editing by David Holmes) 
 ((Marja.Novak@thomsonreuters.com; +386-1-5058805; Reuters 
Messaging: marja.novak.thomsonreuters.com@reuters.net)) 
 
Keywords: SLOVENIA KRKA/SALES